Hemigoxine Nativelle

Hemigoxine Nativelle is a prescription oral medication that contains the cardiac glycoside digoxin. It is marketed in the European Union and is supplied as a tablet (strength not specified). Digoxin works by inhibiting the Na+/K+ ATPase pump, which increases intracellular calcium and enhances cardiac contractility while slowing atrioventricular nodal conduction.

Hemigoxine Nativelle is indicated for the management of certain heart conditions where improved cardiac output and rhythm control are needed.

- Treatment of chronic heart failure to improve symptoms and exercise tolerance. - Rate control in patients with atrial fibrillation or atrial flutter. - Adjunct therapy in patients with congestive cardiomyopathy. - Use in selected cases of supraventricular tachycardia when other agents are unsuitable. - May be employed in palliative care to alleviate dyspnea related to cardiac dysfunction.

Side effects of digoxin can vary in frequency and severity.

Common: - Nausea or vomiting - Diarrhea or abdominal cramps - Fatigue or weakness - Visual disturbances such as blurred vision or yellow‑green halos - Dizziness or headache

Serious: - Cardiac arrhythmias (e.g., premature ventricular beats, atrioventricular block) - Severe bradycardia - Confusion, delirium, or hallucinations - Hyperkalemia or electrolyte imbalance leading to toxicity - Life‑threatening heart block

Before initiating Hemigoxine Nativelle, clinicians should evaluate several safety factors.

- Assess renal function and adjust dose in patients with impaired clearance. - Monitor serum digoxin levels, electrolytes (especially potassium and magnesium), and thyroid function regularly. - Use caution in patients with pre‑existing conduction disorders or bradycardia. - Pregnancy category C: weigh potential benefits against risks; avoid use in the first trimester if possible. - Elderly patients may be more susceptible to toxicity; start at lower doses. - Discontinue or adjust dose before surgery or procedures that may affect fluid balance.

Digoxin interacts with a range of medications that can alter its concentration or cardiac effects.

Avoid: - Strong P‑glycoprotein inhibitors (e.g., amiodarone, quinidine, verapamil) that increase digoxin levels. - Diuretics that cause hypokalemia or hypomagnesemia (e.g., furosemide) which predispose to toxicity. - Certain antibiotics (e.g., erythromycin, clarithromycin) that raise serum digoxin. - Antifungal agents like itraconazole that inhibit metabolism.

Use with caution: - Beta‑blockers and calcium channel blockers that may enhance AV‑node slowing. - Antithyroid drugs or levothyroxine, as thyroid status influences digoxin sensitivity. - NSAIDs that may reduce renal clearance. - St. John’s wort, a P‑glycoprotein inducer, which can lower digoxin concentrations.